Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

824
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
824
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

192
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
192
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

200
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
200
Neural Regulation01:37

Neural Regulation

42.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust Construction of Diffusion MRI Atlases with Correction for Inter-Subject Fiber Dispersion.

Computational diffusion MRI : MICCAI Workshop·2017
Same author

Robust Fusion of Diffusion MRI Data for Template Construction.

Scientific reports·2017
Same author

Learning-Based Multimodal Image Registration for Prostate Cancer Radiation Therapy.

Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention·2017
Same author

Segmenting hippocampal subfields from 3T MRI with multi-modality images.

Medical image analysis·2017
Same author

Joint Discriminative and Representative Feature Selection for Alzheimer's Disease Diagnosis.

Machine learning in medical imaging. MLMI (Workshop)·2017
Same author

Single- and Multiple-Shell Uniform Sampling Schemes for Diffusion MRI Using Spherical Codes.

IEEE transactions on medical imaging·2017

Related Experiment Video

Updated: Dec 13, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.8K

Learning-Based Computer-Aided Prescription Model for Parkinson's Disease: A Data-Driven Perspective.

Yinghuan Shi, Wanqi Yang, Kim-Han Thung

    IEEE Journal of Biomedical and Health Informatics
    |August 6, 2020
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces PALAS, an AI model for automatic prescription recommendations for Parkinson's disease (PD) patients. The model effectively predicts suitable prescriptions based on patient symptoms, showing clinical potential.

    More Related Videos

    Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
    11:12

    Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

    Published on: July 16, 2014

    22.9K
    Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
    05:51

    Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

    Published on: October 14, 2021

    4.2K

    Related Experiment Videos

    Last Updated: Dec 13, 2025

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
    10:28

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

    Published on: July 24, 2019

    15.8K
    Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
    11:12

    Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

    Published on: July 16, 2014

    22.9K
    Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
    05:51

    Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

    Published on: October 14, 2021

    4.2K

    Area of Science:

    • Artificial Intelligence
    • Medical Informatics
    • Computational Neuroscience

    Background:

    • Parkinson's disease (PD) management requires personalized prescription strategies.
    • Accurate symptom-prescription correlation is challenging due to complex patient data.

    Purpose of the Study:

    • To develop an automated system for recommending prescriptions for PD patients.
    • To bridge the semantic gap between patient symptoms and prescribed medications.

    Main Methods:

    • A novel dataset of PD patient symptoms and prescribed drugs was created.
    • A computer-aided prescription model, PALAS (Prescription viA Learning lAtent Symptoms), was developed.
    • PALAS utilizes multi-modality data representation and learns a latent symptom space.

    Main Results:

    • The PALAS model demonstrated effectiveness in recommending prescriptions for PD patients.
    • Experimental results on a dataset of 136 PD patients showed significant potential compared to other methods.
    • An efficient alternating optimization method was employed for model training.

    Conclusions:

    • The developed PALAS model shows promise for automated prescription recommendation in PD.
    • The approach has clinical potential for improving treatment strategies in Parkinson's disease.
    • Further validation on larger datasets could enhance clinical applicability.